Search

Your search keyword '"Miraglia A."' showing total 207 results
Start Over Author "Miraglia A." Journal digestive and liver disease
207 results on '"Miraglia A."'

1. T.07.7: CHARACTERISTICS AND MANAGEMENT OF HEPATOCELLULAR CARCINOMA (HCC) IN SICILY: FIRST RESULTS OF THE HCC SICILY MULTIDISCIPLINARY NETWORK

Author

Celsa, C., primary, Cabibbo, G., additional, Ciccia, R., additional, Di Maria, G., additional, Pagano, D., additional, Miraglia, R., additional, Maruzzelli, L., additional, Bavetta, M.G., additional, Barcellona, M.R., additional, Cocuzza, C., additional, Tavarelli, M., additional, Filomia, R., additional, Pitrone, C., additional, Malizia, G., additional, Bertino, G., additional, Salomone, F., additional, Distefano, M., additional, Mitra, M., additional, Cartabellotta, F., additional, Giannitrapani, L., additional, Giuffrida, D., additional, Spada, M., additional, Alaimo, G., additional, Sambataro, D., additional, Sportato, G., additional, Grassini, M.V., additional, Cannella, R., additional, Antonucci, M., additional, D'Amato, F., additional, Capodicasa, L., additional, Grova, A., additional, Rao, S., additional, Salvato, M., additional, Cusimano, G., additional, Gaudioso, V., additional, Sparacino, A., additional, Mercurio, F., additional, Rizzo, G.E.M., additional, Picciotto, V., additional, Montenegro, R., additional, Arena, S., additional, Saitta, C., additional, Russello, M., additional, Fusco, G., additional, Di Marco, V., additional, Gruttadauria, S., additional, and Cammà, C., additional

Published
2024
Full Text
View/download PDF

9. Contribution of a genetic risk score to clinical prediction of hepatic steatosis in obese children and adolescents

Author

Massimiliano Corradi, Francesca Olivieri, Claudio Maffeis, Giovanni Targher, Marco Dauriz, Christopher D. Byrne, Chiara Zusi, Alessandro Mantovani, Anita Morandi, Luca Valenti, Emanuele Miraglia del Giudice, Zusi, C., Mantovani, A., Olivieri, F., Morandi, A., Corradi, M., Miraglia Del Giudice, E., Dauriz, M., Valenti, L., Byrne, C. D., Targher, G., and Maffeis, C.

Subjects
Male, Pediatric Obesity, Severity of Illness Index, Pediatrics, Gastroenterology, Liver disease, 0302 clinical medicine, Non-alcoholic Fatty Liver Disease, Risk Factors, Nonalcoholic fatty liver disease, Medicine, Child, Membrane Protein, Multivariate Analysi, Pediatric, Genetics, NAFLD, Obesity, Italy, Liver, 030220 oncology & carcinogenesis, Cohort, Regression Analysis, Female, 030211 gastroenterology & hepatology, Human, medicine.medical_specialty, Adolescent, Single-nucleotide polymorphism, Polymorphism, Single Nucleotide, Regression Analysi, 03 medical and health sciences, Genetic, Internal medicine, Humans, Genetic Predisposition to Disease, Genotyping, Adaptor Proteins, Signal Transducing, Hepatology, business.industry, Risk Factor, Membrane Proteins, Lipase, medicine.disease, Genetic Loci, Multivariate Analysis, Steatosis, business, TM6SF2
Abstract

BackgroundNonalcoholic fatty liver disease (NAFLD) is the commonest liver disease in children and adolescents in Western countries. Complex traits arise from the interplay between environmental and genetic factors in the pathogenesis of NAFLD.AimsWe examined the association between NAFLD and eleven single nucleotide polymorphisms (SNPs) at genetic loci potentially associated with liver damage (GCKR, MBOAT7, GPR120), oxidative stress (SOD2), lipid metabolism (PNPLA3, TM6SF2, LPIN1, ELOVL2, FADS2, MTTP) and fibrogenesis (KLF6) in a paediatric population. A genetic risk score (GRS) was performed taking into account both these SNPs and clinical risk factors.MethodsWe recruited a cohort of 514 obese children and adolescents (mean age [±SD]: 11.2 ± 2.8 years, z-BMI 3.3 ± 0.8). NAFLD was identified by ultrasonography. Genotyping was performed by TaqMan-based RT-PCR system.ResultsThe overall prevalence of NAFLD was 67.5% (347 patients). Among the eleven genotyped SNPs, the genetic variants in TM6SF2 rs58542926 (OR = 4.13, p = 0.002), GCKR rs1260326 (OR = 1.53, p = 0.003), PNPLA3 rs738409 (OR = 1.58, p = 0.004) and ELOVL2 rs2236212 (OR = 1.34, p = 0.047) were significantly associated with a higher risk of NAFLD. Addition of a 11-polymorphism GRS to established clinical risk factors significantly (albeit modestly) improved the discriminatory capability of the regression model for predicting the risk of NAFLD (with SNPs C-statistic 0.81 [95%CI 0.75–0.88] vs. 0.77 [0.70–0.84] without SNPs; p = 0.047).ConclusionsNAFLD was strongly associated with three genetic variants, TM6SF2 rs58542926, PNPLA3 rs738409 and GCKR rs1260326, and more slightly with ELOVL2 rs2236212, in obese children and adolescents. Addition of a 11-polymorphism GRS to clinical risk factors improved the predictability of NAFLD.

Published
2019
Full Text
View/download PDF

11. CB2-63 polymorphism and immune-mediated diseases associated with HCV chronic infection

Author

Emanuele Miraglia del Giudice, Margherita Macera, Giulia Bellini, Evangelista Sagnelli, Nicola Coppola, Rosa Zampino, Aldo Marrone, Ivan Gentile, Luigi Elio Adinolfi, Maria Stanzione, Nicolina Capoluongo, Francesca Rossi, Coppola, Nicola, Zampino, Rosa, Bellini, Giulia, Stanzione, Maria, Capoluongo, Nicolina, Marrone, Aldo, Macera, Margherita, Adinolfi, Luigi Elio, Giudice, Emanuele Miraglia Del, Gentile, Ivan, Sagnelli, Evangelista, Rossi, Francesca, Stanzione, M, Capoluongo, N, Macera, M, Giudice, Em, and Gentile, I

Subjects
Adult, Male, medicine.medical_specialty, CB2 polymorphism, Single-nucleotide polymorphism, Hepacivirus, Polymorphism, Single Nucleotide, Gastroenterology, Serology, Receptor, Cannabinoid, CB2, Autoimmune thyroiditis, 03 medical and health sciences, 0302 clinical medicine, Psoriasis, Internal medicine, Epidemiology, medicine, Humans, Autoimmune thyroiditi, Aged, Autoantibodies, Hepatology, business.industry, Medicine (all), Thyroiditis, Autoimmune, Hepatitis C, Chronic, Middle Aged, Non-organ-specific autoantibodie, medicine.disease, Cryoglobulinemia, HCV infection, Lymphoma, Logistic Models, Italy, 030220 oncology & carcinogenesis, Multivariate Analysis, Immunology, Female, 030211 gastroenterology & hepatology, Autoimmune hemolytic anemia, business
Abstract

Aims To evaluate whether CB2 variants are associated with the presence of immune-mediated disorders (IMDs) in patients with chronic HCV infection. Methods One hundred and sixty-eight anti-HCV/HCV-RNA-positive patients were enrolled, 81 with signs of IMDs and 87 without. In the IMDs group, 22 (27.2%) showed ANA positivity (titers ≥1:160), 3 (3.7%) SMA positivity (titers ≥1:160), 24 (29.6%) had cryoglobulinemia, 25 (30.9%) autoimmune thyroiditis, 4 (4.9%) psoriasis, 2 (2.5%) B-cell non-Hodgkin lymphoma and 1 (1.2%) autoimmune hemolytic anemia. All patients were screened for the CNR2 rs35761398 single nucleotide polymorphism using a TaqMan Assay. Results Compared with the 87 patients without IMDs, the 81 with IMDs were more frequently females (65% vs. 45%, p = 0.01), but no significant difference was found in the initial demographic, epidemiological, serological, biochemical or virological data. Instead, the prevalence of patients with the CB2-63 RR variant was significantly higher in the IMD than in the non-IMD group (49.4% vs. 24.1%, p = 0.001). A logistic regression analysis including the CB2-63 receptor (RR vs. QR or QQ), age and sex identified the CB2-63 RR as the only independent predictor of IMDs (p = 0.005). Conclusions The data suggest a significant, previously unknown, independent association between the CB2-63 RR variant and IMDs in anti-HCV-positive patients. The study was approved by the Ethics Committee of the Azienda Ospedaliera Universitaria of the Second University of Naples (n° 214/2012).

Published
2016
Full Text
View/download PDF

12. T01.01.14 THE ROLE OF A NON-INVASIVE TEST IN THE MANAGEMENT OF UPPER-GI DISEASES: COMPARISON BETWEEN SEROLOGY AND ENDOSCOPIC FINDINGS IN A SAMPLE OF 3,795 PATIENTS

Author

Barchi, A., primary, Franceschi, M., additional, Russo, M., additional, Miraglia, C., additional, Crafa, P., additional, Franzoni, L., additional, Ferronato, A., additional, Rodriguez-Castro, K., additional, Baldassarre, G., additional, Panozzo, M.P., additional, Antico, A., additional, Rugge, M., additional, Tursi, A., additional, Brandimarte, G., additional, and Di Mario, F., additional

Published
2020
Full Text
View/download PDF

13. T04.01.12 USEFULNESS OF FECAL CALPROTECTIN IN PRIMARY CARE SETTING: AN EXPERIENCE IN NORTH – EAST ITALY POPULATION

Author

Moccia, F., primary, Ferronato, A., additional, Barchi, A., additional, Miraglia, C., additional, Russo, M., additional, Franceschi, M., additional, Rodriguez-Castro, K., additional, Baldassarre, G., additional, Franzoni, L., additional, Crafa, P., additional, Tursi, A., additional, Brandimarte, G., additional, and Di Mario, F., additional

Published
2020
Full Text
View/download PDF

14. T02.01.20 SEROLOGY AS A DIAGNOSTIC TOOL FOR HELICOBACTER PYLORI INFECTION AND ASSOCIATED CHRONIC INFLAMMATION OF THE STOMACH: A POPULATION STUDY ON 524 PATIENTS

Author

Barchi, A., primary, Franceschi, M., additional, Russo, M., additional, Picchio, M., additional, Miraglia, C., additional, Ferronato, A., additional, Rodriguez-Castro, K., additional, Panozzo, M.P., additional, Baldassarre, G., additional, Franzoni, L., additional, Crafa, P., additional, Rugge, M., additional, and Di Mario, F., additional

Published
2020
Full Text
View/download PDF

17. T01.02.17 CLINICAL USEFULNESS OF SECOND-GENERATION BARRIER DRUGS IN GERD PATIENTS WITH ATYPICAL SYMPTOMS: A-6-MONTHS PROSPECTIVE STUDY

Author

Barchi, A., primary, Russo, M., additional, Miraglia, C., additional, Franzoni, L., additional, Crafa, P., additional, Franceschi, M., additional, Baldassarre, G., additional, Rodriguez-Castro, K., additional, Tursi, A., additional, Brandimarte, G., additional, Savarino, E., additional, De Bortoli, N., additional, and Di Mario, F., additional

Published
2020
Full Text
View/download PDF

18. T01.02.23 ROLE OF ENVIRONMENTAL FACTORS ON THE OUTCOME OF GASTROESOPHAGEAL REFLUX DISEASE: 6 MONTHS PROSPECTIVE STUDY

Author

Russo, M., primary, Barchi, A., additional, Miraglia, C., additional, Franzoni, L., additional, Crafa, P., additional, Franceschi, M., additional, Baldassarre, G., additional, Rodriguez-Castro, K., additional, Tursi, A., additional, Brandimarte, G., additional, Savarino, E., additional, De Bortoli, N., additional, and Di Mario, F., additional

Published
2020
Full Text
View/download PDF

20. OC.08.6 USEFULNESS OF FECAL CALPROTECTIN IN PRIMARY CARE: NON-INVASIVE APPROACH FOR THE FRAMING OF INTESTINAL DISEASES

Author

Moccia, F., primary, Ferronato, A., additional, Franceschi, M., additional, Baldassarre, G., additional, Panozzo, M.P., additional, Antico, A., additional, Barchi, A., additional, Russo, M., additional, Miraglia, C., additional, Franzoni, L., additional, Crafa, P., additional, Tursi, A., additional, Brandimarte, G., additional, and Di Mario, F., additional

Published
2020
Full Text
View/download PDF

23. T01.01.16 CORRELATION BETWEEN SERUM GASTRIC BIOMARKERS AND HISTOLOGICAL PICTURES OF H. PYLORI INFECTION AND ATROPHIC GASTRITIS: A POPULATION STUDY ON 1,122 PATIENTS

Author

Barchi, A., primary, Franceschi, M., additional, Russo, M., additional, Miraglia, C., additional, Crafa, P., additional, Franzoni, L., additional, Ferronato, A., additional, Rodriguez-Castro, K., additional, Baldassarre, G., additional, Panozzo, M.P., additional, Antico, A., additional, Rugge, M., additional, Tursi, A., additional, Brandimarte, G., additional, and Di Mario, F., additional

Published
2020
Full Text
View/download PDF

26. T01.02.17 CLINICAL USEFULNESS OF SECOND-GENERATION BARRIER DRUGS IN GERD PATIENTS WITH ATYPICAL SYMPTOMS: A-6-MONTHS PROSPECTIVE STUDY

Author

A. Barchi, M. Russo, Edoardo Savarino, Chiara Miraglia, Gianluca Baldassarre, N. De Bortoli, K. Rodriguez-Castro, Pellegrino Crafa, F. Di Mario, Giovanni Brandimarte, Marilisa Franceschi, Antonio Tursi, and Lorella Franzoni

Subjects
medicine.medical_specialty, Hepatology, business.industry, Internal medicine, Gastroenterology, GERD, Medicine, Prospective cohort study, business, medicine.disease
Published
2020
Full Text
View/download PDF

27. T01.02.23 ROLE OF ENVIRONMENTAL FACTORS ON THE OUTCOME OF GASTROESOPHAGEAL REFLUX DISEASE: 6 MONTHS PROSPECTIVE STUDY

Author

F. Di Mario, Marilisa Franceschi, Gianluca Baldassarre, Antonio Tursi, N. De Bortoli, Lorella Franzoni, Giovanni Brandimarte, Chiara Miraglia, M. Russo, K. Rodriguez-Castro, Edoardo Savarino, A. Barchi, and Pellegrino Crafa

Subjects
medicine.medical_specialty, Hepatology, business.industry, Internal medicine, Gastroenterology, medicine, Reflux, Disease, Prospective cohort study, business, Outcome (game theory)
Published
2020
Full Text
View/download PDF

28. OC.08.6 USEFULNESS OF FECAL CALPROTECTIN IN PRIMARY CARE: NON-INVASIVE APPROACH FOR THE FRAMING OF INTESTINAL DISEASES

Author

A. Barchi, M. Russo, Gianluca Baldassarre, Antonio Tursi, Marilisa Franceschi, Lorella Franzoni, Antonio Ferronato, Chiara Miraglia, F. Moccia, M.P. Panozzo, Pellegrino Crafa, Antonio Antico, F. Di Mario, and Giovanni Brandimarte

Subjects
medicine.medical_specialty, Framing (social sciences), Hepatology, business.industry, Non invasive, Gastroenterology, medicine, Primary care, Calprotectin, Intensive care medicine, business, Feces
Published
2020
Full Text
View/download PDF

29. T01.02.19 IS IT POSSIBILE TO WITHDRAW PPIS THERAPY IN GERD PATIENTS? A PROSPECTIVE STUDY ON 216 PATIENTS USING A SECOND GENARTION BARRIER DRUG

Author

Antonio Tursi, Lorella Franzoni, Giovanni Brandimarte, N. De Bortoli, Pellegrino Crafa, M. Russo, Marilisa Franceschi, A. Barchi, Edoardo Savarino, F. Di Mario, and Chiara Miraglia

Subjects
Drug, medicine.medical_specialty, Hepatology, business.industry, media_common.quotation_subject, Internal medicine, Gastroenterology, medicine, GERD, medicine.disease, business, Prospective cohort study, media_common
Published
2020
Full Text
View/download PDF

30. T04.02.15 OCCURRENCE OF DIVERTICULAR DISEASE IN COLORECTAL CANCER SCREENING: A 3-YEAR STUDY ON 2,104 PATIENTS

Author

Gianluca Baldassarre, Antonio Tursi, Lorella Franzoni, R. Cannizzaro, M. Russo, Marilisa Franceschi, Giovanni Brandimarte, Massimo Rugge, Pellegrino Crafa, Chiara Miraglia, A. Barchi, and F. Di Mario

Subjects
medicine.medical_specialty, Hepatology, Colorectal cancer screening, business.industry, Internal medicine, Gastroenterology, medicine, Diverticular disease, business
Published
2020
Full Text
View/download PDF

31. T04.01.12 USEFULNESS OF FECAL CALPROTECTIN IN PRIMARY CARE SETTING: AN EXPERIENCE IN NORTH – EAST ITALY POPULATION

Author

Giovanni Brandimarte, Gianluca Baldassarre, Marilisa Franceschi, A. Barchi, K. Rodriguez-Castro, Pellegrino Crafa, M. Russo, Antonio Ferronato, F. Di Mario, Antonio Tursi, Lorella Franzoni, F. Moccia, and Chiara Miraglia

Subjects
education.field_of_study, Hepatology, business.industry, Environmental health, Population, Gastroenterology, Medicine, Primary care, North east, Calprotectin, business, education, Feces
Published
2020
Full Text
View/download PDF

32. Circulatory response to volume expansion and transjugular intrahepatic portosystemic shunt in refractory ascites: Relationship with diastolic dysfunction

Author

Daniela Filì, Roberto Miraglia, Calogero Falletta, Giovanni Vizzini, Francesco Clemenza, Bruno Gridelli, Jaime Bosch, Fabio Tuzzolino, Cesare Scardulla, Cesar Mario Hernandez Baravoglia, and Angelo Luca

Subjects
Adult, Liver Cirrhosis, Male, Cardiac Catheterization, medicine.medical_specialty, medicine.medical_treatment, Cardiac index, Diastole, Electrocardiography, Internal medicine, Natriuretic Peptide, Brain, medicine, Humans, Prospective Studies, Pulmonary wedge pressure, Aged, Cardiac catheterization, Heart Failure, Diastolic, Hepatology, business.industry, Hemodynamics, Gastroenterology, Ascites, Middle Aged, medicine.disease, Peptide Fragments, medicine.anatomical_structure, Echocardiography, Spain, Heart failure, Heart catheterization, Vascular resistance, Cardiology, Female, Vascular Resistance, Portasystemic Shunt, Transjugular Intrahepatic, business, Transjugular intrahepatic portosystemic shunt
Abstract

Background Cirrhotic cardiomyopathy may lead to heart failure in stressful circumstances, such as after transjugular intrahepatic portosystemic shunt (TIPS) placement. Aim To examine whether acute volume expansion predicts haemodynamic changes after TIPS and elicits signs of impending heart failure. Methods We prospectively evaluated refractory ascites patients (group A) and compensated cirrhotics (group B), who underwent echocardiography, NT-proBNP measurement, and heart catheterization before and after volume load; group A repeated measurements after TIPS. Results 15 patients in group A (80% male; 54 ± 12.4 years) and 8 in group B (100% male; 56 ± 6.2 years) were enrolled. Echocardiography disclosed diastolic dysfunction in 30% and 12.5%, respectively. In group A, volume load and TIPS induced a significant increase in right atrial, mean pulmonary, capillary wedge pressure and cardiac index, and a decrease in systemic vascular resistance (respectively, 4.7 ± 2.8 vs. 9.9 ± 3.6 mmHg; 13.3 ± 3.5 vs. 21.9 ± 5.9 mmHg; 8.3 ± 3.4 vs. 15.4 ± 4.7 mmHg; 3.7 ± 0.7 vs. 4.6 ± 1 lt/min/m 2 ; 961 ± 278 vs. 767 ± 285 dyn s cm −5 ; and 10.1 ± 3.3 vs. 14.2 ± 3.4 mmHg; 17.5 ± 4 vs. 25.2 ± 4.2 mmHg; 12.3 ± 4 vs. 19.3 ± 3.4 mmHg; 3.4 ± 0.8 vs. 4.5 ± 0.91 lt/min/m 2 ; 779 ± 62 vs. 596 ± 199 dyn s cm −5 , p Conclusions Acute volume expansion predicted haemodynamic changes immediately after TIPS. All patients had adequate haemodynamic adaptation to TIPS; none developed signs of heart failure.

Published
2015
Full Text
View/download PDF

34. OC.08.4 RISK FACTORS FOR ENDOSCOPIC SEVERITY OF DIVERTICULAR DISEASE OF THE COLON AND ITS OUTCOME: A REAL-LIFE CASE-CONTROL STUDY

Author

Antonio Tursi, Marcello Picchio, A. Violi, Walter Elisei, G. Cambiè, Marilisa Franceschi, Chiara Miraglia, Giovanni Brandimarte, Gianluca Baldassarre, and F. Di Mario

Subjects
medicine.medical_specialty, Hepatology, business.industry, Internal medicine, Gastroenterology, medicine, Case-control study, Diverticular disease, business, Outcome (game theory)
Published
2020
Full Text
View/download PDF

35. T01.01.14 THE ROLE OF A NON-INVASIVE TEST IN THE MANAGEMENT OF UPPER-GI DISEASES: COMPARISON BETWEEN SEROLOGY AND ENDOSCOPIC FINDINGS IN A SAMPLE OF 3,795 PATIENTS

Author

Marilisa Franceschi, Antonio Antico, Gianluca Baldassarre, Massimo Rugge, Antonio Tursi, Lorella Franzoni, A. Barchi, M. Russo, M.P. Panozzo, Pellegrino Crafa, F. Di Mario, Antonio Ferronato, Giovanni Brandimarte, Chiara Miraglia, and K. Rodriguez-Castro

Subjects
medicine.medical_specialty, Hepatology, Non invasive test, business.industry, Internal medicine, Gastroenterology, Medicine, Sample (statistics), business, Serology
Published
2020
Full Text
View/download PDF

36. T01.01.24 RISK FACTORS OF EARLY AND ADVANCED GASTRIC CANCER: A 8 YEARS POPULATION STUDY IN NORTHERN ITALY

Author

Giovanni Brandimarte, Chiara Miraglia, Antonio Tursi, Marilisa Franceschi, Lorella Franzoni, Massimo Rugge, Gianluca Baldassarre, Pellegrino Crafa, A. Barchi, M. Russo, R. Cannizzaro, O. Cavatorta, and F. Di Mario

Subjects
Hepatology, business.industry, Gastroenterology, Medicine, Population study, Advanced gastric cancer, business, Demography, Northern italy
Published
2020
Full Text
View/download PDF

37. T02.01.20 SEROLOGY AS A DIAGNOSTIC TOOL FOR HELICOBACTER PYLORI INFECTION AND ASSOCIATED CHRONIC INFLAMMATION OF THE STOMACH: A POPULATION STUDY ON 524 PATIENTS

Author

Gianluca Baldassarre, K. Rodriguez-Castro, F. Di Mario, Pellegrino Crafa, M.P. Panozzo, Antonio Ferronato, A. Barchi, M. Russo, Marilisa Franceschi, Massimo Rugge, Lorella Franzoni, Chiara Miraglia, and Marcello Picchio

Subjects
medicine.medical_specialty, Helicobacter pylori infection, Hepatology, business.industry, Stomach, Gastroenterology, Inflammation, Serology, medicine.anatomical_structure, Internal medicine, Medicine, Population study, medicine.symptom, business
Published
2020
Full Text
View/download PDF

38. T02.01.7 IS HELICOBACTER PYLORI CURE A LONG-LIFE STRATEGY? A 25 YEARS SURVEY ON 693 PATIENTS

Author

Antonio Tursi, Lorella Franzoni, Marilisa Franceschi, Pellegrino Crafa, Massimo Rugge, N. Dal Bò, M. Russo, Giovanni Brandimarte, A. Barchi, R. Cannizzaro, F. Di Mario, and Chiara Miraglia

Subjects
medicine.medical_specialty, Hepatology, biology, business.industry, Internal medicine, Gastroenterology, medicine, Helicobacter pylori, biology.organism_classification, business
Published
2020
Full Text
View/download PDF

39. T01.01.16 CORRELATION BETWEEN SERUM GASTRIC BIOMARKERS AND HISTOLOGICAL PICTURES OF H. PYLORI INFECTION AND ATROPHIC GASTRITIS: A POPULATION STUDY ON 1,122 PATIENTS

Author

Antonio Tursi, Lorella Franzoni, Gianluca Baldassarre, Chiara Miraglia, F. Di Mario, Antonio Ferronato, A. Barchi, Pellegrino Crafa, Antonio Antico, M.P. Panozzo, K. Rodriguez-Castro, Marilisa Franceschi, Massimo Rugge, M. Russo, and Giovanni Brandimarte

Subjects
medicine.medical_specialty, Hepatology, Atrophic gastritis, business.industry, Internal medicine, Gastroenterology, medicine, Population study, H pylori infection, medicine.disease, business
Published
2020
Full Text
View/download PDF

40. Sarcopenia correlates with mortality in cirrhotic patients who undergo transjugular intrahepatic portosystemic shunt creation for refractory ascites

Author

Jaime Bosch, Ioannis Petridis, Riccardo Volpes, Luigi Maruzzelli, Annalisa Berzigotti, Roberto Miraglia, and T. Wan

Subjects
medicine.medical_specialty, Hepatology, business.industry, Internal medicine, medicine.medical_treatment, Sarcopenia, Gastroenterology, medicine, Refractory ascites, business, medicine.disease, Transjugular intrahepatic portosystemic shunt
Published
2020
Full Text
View/download PDF

41. PC.01.2 ATROPHIC GASTRITIS IN ALL-CAUSE UPPER GASTROINTESTINAL ENDOSCOPY AT A TERTIARY ENDOSCOPIC CENTER: SEVERITY ACCORDING TO THE OLGA STAGING SYSTEM

Author

K. Rodriguez-Castro, A. Morini, B. Pertoldi, Marilisa Franceschi, Chiara Miraglia, Gianluca Baldassarre, F. Di Mario, D. Sella, L. Cuoco, R.L. Gasparri, and Antonio Ferronato

Subjects
medicine.medical_specialty, Hepatology, business.industry, Atrophic gastritis, Gastroenterology, medicine, Center (algebra and category theory), Radiology, business, medicine.disease, Staging system, Upper gastrointestinal endoscopy, All cause mortality
Published
2019
Full Text
View/download PDF

42. P.01.25 CAN A NON-INVASIVE TEST PREDICT THE RESULTS OF PH-IMPEDANCE? PROSPECTIVE STUDY OF A COHORT OF PATIENTS WITH EXTRA-ESOPHAGEAL MANIFESTATIONS OF GERD

Author

Edoardo Savarino, S. Cesario, N. De Bortoli, H. Singh, Santino Marchi, T. Di Chio, Lorella Franzoni, F. Di Mario, Pellegrino Crafa, Antonio Nouvenne, M. Zari, and Chiara Miraglia

Subjects
medicine.medical_specialty, Hepatology, Non invasive test, business.industry, Internal medicine, Cohort, Gastroenterology, medicine, GERD, medicine.disease, business, Prospective cohort study
Published
2019
Full Text
View/download PDF

43. OC.05.6 THE PROGNOSTIC VALUE OF A NEW ENDOSCOPIC CLASSIFICATION FOR DIVERTICULAR DISEASE: DICA (DIVERTICULAR INFLAMMATION AND COMPLICATION ASSESSMENT)

Author

Antonio Tursi, Lorella Franzoni, Antonio Nouvenne, G. Cambiè, F. Di Mario, A. Violi, Pellegrino Crafa, Gianluca Baldassarre, K. Rodriguez-Castro, Chiara Miraglia, Marilisa Franceschi, and Giovanni Brandimarte

Subjects
medicine.medical_specialty, Hepatology, business.industry, Internal medicine, Gastroenterology, medicine, Diverticular disease, Inflammation, medicine.symptom, Complication, business, Value (mathematics)
Published
2019
Full Text
View/download PDF

45. P.01.31 A COMPARISON OF DIFFERENT TREATMENTS FOR SYMPTOMATIC REFLUX ESOPHAGITIS: A REAL-LIFE STUDY

Author

Chiara Miraglia, Pellegrino Crafa, Antonio Nouvenne, Marilisa Franceschi, N. De Bortoli, Marcello Picchio, Edoardo Savarino, F. Di Mario, Giovanni Brandimarte, Antonio Tursi, Lorella Franzoni, and Walter Elisei

Subjects
medicine.medical_specialty, Hepatology, business.industry, Internal medicine, Gastroenterology, medicine, Reflux esophagitis, Life study, business
Published
2019
Full Text
View/download PDF

50. P.01.25 CAN A NON-INVASIVE TEST PREDICT THE RESULTS OF PH-IMPEDANCE? PROSPECTIVE STUDY OF A COHORT OF PATIENTS WITH EXTRA-ESOPHAGEAL MANIFESTATIONS OF GERD

Author

Cesario, S., primary, De Bortoli, N., additional, Savarino, E., additional, Singh, H., additional, Zari, M., additional, Di Chio, T., additional, Miraglia, C., additional, Franzoni, L., additional, Nouvenne, A., additional, Crafa, P., additional, Marchi, S., additional, and Di Mario, F., additional

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results